article thumbnail

New Data Protection-Friendly eCommercial Model Clinical Trial Agreements Now Available

HL Chronicle of Data Protection

Given the increasing importance of safe but swift clinical trials in the time of coronavirus, this post outlines the main changes introduced from a data protection perspective and what they mean for contracting parties. New Clause 6.3

GDPR 90
article thumbnail

Privacy and Cybersecurity Top 10 for 2018

Data Matters

This past year was marked by ever more significant data breaches, growing cybersecurity regulatory requirements at the state and federal levels and continued challenges in harmonizing international privacy and cybersecurity regulations. Data breach litigation risks. We expect each of these trends to continue in 2018.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The hidden threats facing your intellectual property

IT Governance

When we consider the damage a data breach can cause, we tend to focus on the cost of breach reporting, potential fines and loss of reputation. For life sciences and pharmaceutical companies, this includes data on the development and testing of new therapies and details of how therapies are manufactured.

article thumbnail

2019 end-of-year review part 1: January to June

IT Governance

More than 770 million people learned their email addresses had been made public in what would be known as the ‘Collection #1’ data breach. Sensitive data belonging to hundreds of German politicians and public figures was published online. Mumsnet disclosed a data breach affecting 4,000 people. million (£4.2

article thumbnail

Security in a World of Physically Capable Computers

Schneier on Security

The practice of patching a security vulnerability is a good example of this. The National Institute of Standards and Technology's Cybersecurity Framework is an excellent example of this, because its recommendations can be tailored to suit the individual needs and risks of organizations.

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

However, even organizations that do not qualify as a “business” may nonetheless need to evaluate their data sharing arrangements and partnerships with CCPA-covered entities. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data. Is the data medical information?

Privacy 45
article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

However, even organizations that do not qualify as a “business” may nonetheless need to evaluate their data sharing arrangements and partnerships with CCPA-covered entities. It will be important for a company to assess the scope of the CMIA’s application to its activities and various types of data. Is the data medical information?

Privacy 40